Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 22, 2024 Filed Jan 25, 2024 11:03 UTC |
Kalin Katherine BachDirector
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006401 · tm243935-3_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:02 UTC |
Francomano RobertChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006396 · tm243935-2_4seq1.xml · derivative · entry 2 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:02 UTC |
Francomano RobertChief Commercial Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006396 · tm243935-2_4seq1.xml · nonDerivative · entry 1 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,918 F1 · shares: The Reporting Person received an award of 20,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 11:00 UTC | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001104659-24-006379 · tm243935-1_4seq1.xml · derivative · entry 2 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-01-22 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
|
| January 22, 2024 Filed Jan 25, 2024 11:00 UTC | GrantCommon Stock | 47,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-006379 · tm243935-1_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,927 F1 · shares: The Reporting Person received an award of 47,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
|
| December 06, 2023 Filed Dec 8, 2023 16:11 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
OtherClass A Common Stock | 4,119 | $1.08 | $4,448.52 |
DisclosureSEC source: 0001104659-23-124690 · tm2332459-4_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,225 F1 · kind: Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:10 UTC |
Stergiou Angelos M.Director · President and CEO
|
OtherClass A Common Stock | 12,268 | $1.08 | $13,249.44 |
DisclosureSEC source: 0001104659-23-124688 · tm2332459-3_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,421 F1 · kind: Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:10 UTC |
Francomano RobertChief Commercial Officer
|
OtherClass A Common Stock | 1,082 | $1.08 | $1,168.56 |
DisclosureSEC source: 0001104659-23-124687 · tm2332459-2_4seq1.xml · nonDerivative · entry 1 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,918 F1 · kind: Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:10 UTC | OtherClass A Common Stock | 2,929 | $1.08 | $3,163.32 |
DisclosureSEC source: 0001104659-23-124686 · tm2332459-1_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,927 F1 · kind: Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs"). F2 · shares: Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. Read SEC document |
|
| February 02, 2023 Filed Feb 3, 2023 17:14 UTC |
Varian JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010635 · tm235353d5_4seq1.xml · derivative · entry 2 Varian John · CIK 0001416176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:14 UTC |
Varian JohnDirector
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010635 · tm235353d5_4seq1.xml · nonDerivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:18 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010654 · tm235353d9_4seq1.xml · derivative · entry 2 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:18 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010654 · tm235353d9_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,344 F1 · shares: The Reporting Person received an award of 20,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:11 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010623 · tm235353d3_4seq1.xml · derivative · entry 2 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:11 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010623 · tm235353d3_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:11 UTC |
SCHEINBERG DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010619 · tm235353d2_4seq1.xml · derivative · entry 2 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 17:11 UTC |
SCHEINBERG DAVID ADirector
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010619 · tm235353d2_4seq1.xml · nonDerivative · entry 1 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:13 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010629 · tm235353d4_4seq1.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:13 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010629 · tm235353d4_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:15 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 217,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010638 · tm235353d7_4seq1.xml · derivative · entry 2 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,500 Underlying: Common Stock · 217,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:15 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 58,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010638 · tm235353d7_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,689 F1 · shares: The Reporting Person received an award of 58,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date.date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:17 UTC | GrantStock Option Right to Buy) · Derivative | 75,000 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010643 · tm235353d8_4seq1.xml · derivative · entry 2 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
|
| February 02, 2023 Filed Feb 3, 2023 22:17 UTC | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010643 · tm235353d8_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,347 F1 · shares: The Reporting Person received an award of 20,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
|
| February 02, 2023 Filed Feb 3, 2023 22:14 UTC |
Francomano RobertChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010637 · tm235353d6_4seq1.xml · derivative · entry 2 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:14 UTC |
Francomano RobertChief Commercial Officer
|
GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010637 · tm235353d6_4seq1.xml · nonDerivative · entry 1 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · shares: The Reporting Person received an award of 12,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:10 UTC |
Kalin Katherine BachDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001104659-23-010613 · tm235353d1_4seq1.xml · derivative · entry 2 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2033-02-02 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:10 UTC |
Kalin Katherine BachDirector
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-010613 · tm235353d1_4seq1.xml · nonDerivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 16:12 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
SaleClass A Common Stock | 2,153 | $2.59 | $5,576.27 |
DisclosureSEC source: 0001104659-22-124565 · tm2232008-1_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,344 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 21:14 UTC |
Stergiou Angelos M.Director · President and CEO
|
SaleClass A Common Stock | 6,494 | $2.61 | $16,938.30 |
DisclosureSEC source: 0001104659-22-124568 · tm2232008-3_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,689 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $2.58 to $2.66, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 21:13 UTC |
Burns John ThomasSenior VP, Finance & CAO
|
SaleClass A Common Stock | 1,159 | $2.59 | $3,001.81 |
DisclosureSEC source: 0001104659-22-124566 · tm2232008-2_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · Senior VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,347 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| August 13, 2022 Filed Aug 16, 2022 20:08 UTC |
Kalin Katherine BachDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001104659-22-091751 · tm2223585-1_4seq1.xml · derivative · entry 1 Kalin Katherine Bach · CIK 0001832671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2032-08-13 F1 · derivative.exercise_date: The shares subject to the option will fully vest on August 13, 2023. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:05 UTC |
Francomano RobertChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001104659-22-033927 · tm229354-1_4seq1.xml · derivative · entry 1 Francomano Robert · CIK 0001797467 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-14 F1 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 14, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:06 UTC |
Varian JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,125 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010399 · tm225088-5_4seq1.xml · derivative · entry 2 Varian John · CIK 0001416176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2032-01-31 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:06 UTC |
Varian JohnDirector
|
GrantCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010399 · tm225088-5_4seq1.xml · nonDerivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · shares: The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:07 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantStock Option (Right to Buy) · Derivative | 48,750 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010401 · tm225088-7_4seq1.xml · derivative · entry 2 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,750 Underlying: Common Stock · 48,750 shares Expires 2032-01-31 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:07 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
GrantCommon Stock | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010401 · tm225088-7_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,028 F1 · shares: The Reporting Person received an award of 13,000 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:06 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,125 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010397 · tm225088-4_4seq1.xml · derivative · entry 2 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2032-01-31 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:06 UTC |
VAN NOSTRAND ROBERT LDirector
|
GrantCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010397 · tm225088-4_4seq1.xml · nonDerivative · entry 1 VAN NOSTRAND ROBERT L · CIK 0001225198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · shares: The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:05 UTC |
SCHEINBERG DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 7,125 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010393 · tm225088-2_4seq1.xml · derivative · entry 2 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2032-01-31 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 17:05 UTC |
SCHEINBERG DAVID ADirector
|
GrantCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010393 · tm225088-2_4seq1.xml · nonDerivative · entry 1 SCHEINBERG DAVID A · CIK 0001250316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,082 F1 · shares: The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:07 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,125 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010400 · tm225088-6_4seq1.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2032-01-31 F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:07 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010400 · tm225088-6_4seq1.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · shares: The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:06 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 165,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010396 · tm225088-3_4seq1.xml · derivative · entry 2 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2032-01-31 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:06 UTC |
Stergiou Angelos M.Director · President and CEO
|
GrantCommon Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010396 · tm225088-3_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,167 F1 · shares: The Reporting Person received an award of 44,000 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:05 UTC |
Burns John ThomasSenior VP, Finance & CAO
|
GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001104659-22-010391 · tm225088-1_4seq1.xml · derivative · entry 2 Burns John Thomas · CIK 0001568734 · Senior VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2032-01-31 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:05 UTC |
Burns John ThomasSenior VP, Finance & CAO
|
GrantCommon Stock | 9,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-010391 · tm225088-1_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · Senior VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,244 F1 · shares: The Reporting Person received an award of 9,600 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 17:14 UTC |
WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.
|
SaleCommon Stock | 847 | $6.25 | $5,297.73 |
DisclosureSEC source: 0001104659-21-146422 · tm2134552-5_4seq1.xml · nonDerivative · entry 1 WOOD BARBARA A · CIK 0001220051 · EVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,028 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:15 UTC |
Stergiou Angelos M.Director · President and CEO
|
SaleCommon Stock | 2,120 | $6.25 | $13,251.91 |
DisclosureSEC source: 0001104659-21-146424 · tm2134552-6_4seq1.xml · nonDerivative · entry 1 Stergiou Angelos M. · CIK 0001724253 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,167 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:13 UTC |
Burns John ThomasVP, Finance & Corp Controller
|
SaleCommon Stock | 231 | $6.27 | $1,447.75 |
DisclosureSEC source: 0001104659-21-146421 · tm2134552-4_4seq1.xml · nonDerivative · entry 1 Burns John Thomas · CIK 0001568734 · VP, Finance & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,644 F1 · shares: Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:29 UTC |
Varian JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001104659-21-033300 · tm218923d6_4.xml · derivative · entry 1 Varian John · CIK 0001416176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-03-04 F1 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) March 4, 2022 (the first anniversary of the date of grant) or (y) the business day prior to the 2022 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.